We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$481B
AUM Growth
+$34.6B
Cap. Flow
+$38.1B
Cap. Flow %
7.92%
Top 10 Hldgs %
29.35%
Holding
15,428
New
1,885
Increased
5,794
Reduced
5,768
Closed
1,724

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.26B
2
MSFT icon
Microsoft
MSFT
+$633M
3
BABA icon
Alibaba
BABA
+$501M
4
ATVI
Activision Blizzard
ATVI
+$484M
5
AAPL icon
Apple
AAPL
+$456M

Sector Composition

Rank Sector Weight
1 Technology 3.08%
2 Consumer Discretionary 2.25%
3 Financials 2.23%
4 Healthcare 2.22%
5 Industrials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HISF icon
3401
First Trust Exchange-Traded Fund IV First Trust High Income Strategic Focus ETF
HISF
$99M
$7.82M ﹤0.01%
158,769
+112,048
+240% +$5.62M
ZG icon
3402
Zillow
ZG
$7.91B
$7.81M ﹤0.01%
88,175
+51,899
+143% +$5.29M
ACMR icon
3403
CALL
ACM Research
ACMR
$5.6B
$7.81M ﹤0.01%
213,000
-25,800
-11% -$789K
RVNC
3404
PUT
DELISTED
Revance Therapeutics, Inc.
RVNC
$7.8M ﹤0.01%
280,100
+11,300
+4% +$322K
AMP icon
3405
CALL
Ameriprise Financial
AMP
$50.3B
$7.79M ﹤0.01%
29,500
+2,100
+8% +$549K
ING icon
3406
ING
ING
$102B
$7.79M ﹤0.01%
537,403
+462,830
+621% +$6.18M
EWG icon
3407
iShares MSCI Germany ETF
EWG
$1.68B
$7.78M ﹤0.01%
236,214
+200,186
+556% +$6.92M
IMTM icon
3408
iShares MSCI Intl Momentum Factor ETF
IMTM
$4.33B
$7.77M ﹤0.01%
204,002
+56,948
+39% +$2.24M
RGLD icon
3409
PUT
Royal Gold
RGLD
$19.5B
$7.76M ﹤0.01%
81,300
-19,100
-19% -$2.14M
EWP icon
3410
iShares MSCI Spain ETF
EWP
$2.22B
$7.76M ﹤0.01%
287,789
+279,909
+3,552% +$7.81M
DHBC
3411
DELISTED
DHB Capital Corp. Class A common stock
DHBC
$7.75M ﹤0.01%
799,379
+299,279
+60% +$2.89M
JAZZ icon
3412
CALL
Jazz Pharmaceuticals
JAZZ
$15.9B
$7.75M ﹤0.01%
59,540
-43,248
-42% -$6.53M
AILE
3413
DELISTED
iLearningEngines, Inc. Common Stock
AILE
$7.73M ﹤0.01%
796,978
+258,939
+48% +$2.5M
RETA
3414
CALL
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$7.73M ﹤0.01%
76,800
+19,900
+35% +$2.33M
WEC icon
3415
CALL
WEC Energy
WEC
$36B
$7.73M ﹤0.01%
87,600
+63,800
+268% +$5.98M
ESNT icon
3416
Essent Group
ESNT
$6.25B
$7.72M ﹤0.01%
175,350
-252,611
-59% -$11.5M
JYAC
3417
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
$7.71M ﹤0.01%
788,778
-3,754
-0.5% -$36.6K
AEAC
3418
DELISTED
Authentic Equity Acquisition Corp. Class A ordinary share
AEAC
$7.71M ﹤0.01%
795,017
+288,811
+57% +$2.8M
AU icon
3419
CALL
AngloGold Ashanti
AU
$48.7B
$7.71M ﹤0.01%
482,100
+151,200
+46% +$2.62M
CCK icon
3420
PUT
Crown Holdings
CCK
$12.9B
$7.69M ﹤0.01%
76,300
+10,900
+17% +$1.14M
HCII
3421
DELISTED
Hudson Executive Investment Corp. II Class A Common Stock
HCII
$7.69M ﹤0.01%
788,752
+438,752
+125% +$4.27M
ATER icon
3422
PUT
Aterian
ATER
$5.44M
$7.68M ﹤0.01%
59,125
+55,708
+1,630% +$6.18M
NWL icon
3423
CALL
Newell Brands
NWL
$2.66B
$7.68M ﹤0.01%
346,900
+130,500
+60% +$3.33M
KCGI.U
3424
DELISTED
Kensington Capital Acquisition Corp. V Units, each consisting of one Class A ordinary share and three-fourths of one redeemable warrant
KCGI.U
$7.67M ﹤0.01%
+751,979
New +$7.61M
GHYB icon
3425
Goldman Sachs Access High Yield Corporate Bond ETF
GHYB
$134M
$7.66M ﹤0.01%
152,874
+116,486
+320% +$5.84M

Similar funds

Ken Griffin's Q3 2021 Portfolio in Review

As of Q3 2021, Ken Griffin held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Ken Griffin deployed $38.1B of net new capital in Q3 2021, opening 1,885 new positions and adding to 5,794 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, down from 3.2% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.

  • Ken Griffin's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
  • Ken Griffin added most to Tesla in Q3 2021, an estimated $1.26B increase.
  • Ken Griffin's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
  • Ken Griffin fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
  • Ken Griffin's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
  • Ken Griffin opened 1,885 new positions and closed 1,724 in Q3 2021.
  • Ken Griffin's portfolio value rose 7.8% quarter-over-quarter to $481B.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.